GC
KNSA icon

Globeflex Capital’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Globeflex Capital’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.97M Hold
93,396
– – 0.76% 35
2026
Q1 		$4.5M Hold
93,396
– – 0.68% 45
2025
Q4 		$3.85M Hold
93,396
– – 0.59% 59
2025
Q3 		$3.63M Buy
93,396
+4,800
+5% +$156K 0.56% 58
2025
Q2 		$2.45M Hold
88,596
– – 0.2% 110
2025
Q1 		$1.97M Hold
88,596
– – 0.18% 112
2024
Q4 		$1.75M Buy
88,596
+60,656
+217% +$1.38M 0.15% 126
2024
Q3 		$698K Buy
27,940
+21,150
+311% +$515K 0.07% 233
2024
Q2 		$127K Buy
+6,790
New +$127K 0.01% 345
2023
Q4 		– Sell
-9,338
Closed -$162K – 494
2023
Q3 		$162K Buy
+9,338
New +$157K 0.02% 338

Other funds holding KNSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

Globeflex Capital's KNSA Position: Q2 2026 in Review

Globeflex Capital held its Kiniksa Pharmaceuticals (KNSA) position steady in Q2 2026 at 93,396 shares worth $5.97M. The position accounts for 0.76% of the portfolio, ranked #35.

Globeflex Capital first reported a position in KNSA in Q3 2023 and has held it in 10 quarters since. 266 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

  • Globeflex Capital held 93,396 shares of Kiniksa Pharmaceuticals worth $5.97M as of Q2 2026.
  • Globeflex Capital left its Kiniksa Pharmaceuticals share count unchanged in Q2 2026.
  • Kiniksa Pharmaceuticals made up 0.76% of Globeflex Capital's portfolio in Q2 2026, its #35 holding.
  • Globeflex Capital first reported a position in Kiniksa Pharmaceuticals in Q3 2023 and has held it in 10 quarters since.
  • 266 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on Globeflex Capital's 13F filing for Q2 2026, filed 12 Aug 2026.